KP Tissue (KP8) Stock Overview

Through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. More details

KP8 fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	2/6
Past Performance	4/6
Financial Health	6/6
Dividends	4/6

Rewards

Trading at 96.2% below our estimate of its fair value

Revenue is forecast to grow 76.27% per year

Earnings grew by 249.5% over the past year

Pays a reliable dividend of 6.49%

Risk Analysis

Makes less than USD$1m in revenue (CA$0)

Does not have a meaningful market cap (€110M)

KP8 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

KP Tissue Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for KP Tissue
Historical stock prices
Current Share Price	CA$6.80
52 Week High	CA$6.95
52 Week Low	CA$6.15
Beta	0.38
1 Month Change	3.82%
3 Month Change	8.80%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	-7.48%
Change since IPO	-48.84%

Recent updates

Shareholder Returns

	KP8	DE Household Products	DE Market
7D	-0.7%	-5.3%	-4.5%
1Y	n/a	-8.0%	-4.8%

Return vs Industry: Insufficient data to determine how KP8 performed against the German Household Products industry.

Return vs Market: Insufficient data to determine how KP8 performed against the German Market.

Price Volatility

Is KP8's price volatile compared to industry and market?
KP8 volatility
KP8 Average Weekly Movement	2.4%
Household Products Industry Average Movement	4.1%
Market Average Movement	6.0%
10% most volatile stocks in DE Market	14.1%
10% least volatile stocks in DE Market	2.7%

Stable Share Price: KP8 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine KP8's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2012	n/a	Dino Bianco	www.kptissueinc.com

KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through the Consumer and Away-From-Home segments. It offers bathroom and facial tissues, paper towels, and napkins.

KP Tissue Inc. Fundamentals Summary

How do KP Tissue's earnings and revenue compare to its market cap?
KP8 fundamental statistics
Market cap	€68.69m
Earnings (TTM)	€5.33m
Revenue (TTM)	n/a

13.1x

P/E Ratio

0.0x

P/S Ratio

Is KP8 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KP8 income statement (TTM)
Revenue	CA$0
Cost of Revenue	CA$0
Gross Profit	CA$0
Other Expenses	-CA$8.50m
Earnings	CA$8.50m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	0.85
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0%

How did KP8 perform over the long term?

See historical performance and comparison

Dividends

6.5%

Current Dividend Yield

85%

Payout Ratio

Does KP8 pay a reliable dividends?

See KP8 dividend history and benchmarks

When do you need to buy KP8 by to receive an upcoming dividend?
KP Tissue dividend dates
Ex Dividend Date	Mar 31 2026
Dividend Pay Date	Apr 15 2026
Days until Ex dividend	5 days
Days until Dividend pay date	20 days

Does KP8 pay a reliable dividends?

See KP8 dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/03/24 20:57
End of Day Share Price	2026/03/24 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

KP Tissue Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Hamir Patel	CIBC Capital Markets
Frederic Tremblay	Desjardins Securities Inc.
Zachary Evershed	National Bank Financial

KP Tissue Inc.DB:KP8 Stock Report